| Date | Form | Description | Docs | XBRL | Pages |
| 12/08/22 | 8-K | Current report filing |
|
|
5 |
| 11/01/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/30/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/29/22 | 8-K | Current report filing |
|
|
14 |
| 09/19/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/15/22 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 09/14/22 | UPLOAD | SEC-generated letter |
|
1 | |
| 09/12/22 | DEL AM | Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement |
|
1 |
Latest News & Events
Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
Read More...Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Read More...Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy
Read More...